Ypsomed Holding AG Logo

Ypsomed Holding AG

Develops self-injection systems for pharma/biotech partners to simplify chronic disease therapy.

YPSN | SW

Overview

Corporate Details

ISIN(s):
CH0019396990
LEI:
391200QLIOTTBNPNSI14
Country:
Switzerland
Address:
Brunnmattstrasse 6, 3400 Burgdorf
Sector:
Manufacturing
Industry:
Manufacture of medical and dental instruments and supplies

Description

Ypsomed Holding AG is a leading developer and manufacturer of self-injection and infusion systems for self-medication. The company partners with pharmaceutical and biotech companies, providing a comprehensive portfolio of innovative platforms including injection pens, autoinjectors, and on-body devices. For over 40 years, Ypsomed has offered tailored self-care solutions designed to simplify therapy and improve quality of life for people with chronic conditions. Its platform ecosystem combines industrialized drug delivery technology with expert support services and integrated digital health solutions that support therapy management and clinical trials.

Social Media

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all Ypsomed Holding AG filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Ypsomed Holding AG

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Ypsomed Holding AG via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
2024-09-30 N/A Executive member Buy None 145,600.00 CHF
2024-09-26 N/A Executive member Sell None 129,352.00 CHF
2024-09-24 N/A Non-Executive member Buy None 42,776.00 CHF
2024-05-27 N/A Executive member Sell None 78,000.00 CHF
2024-05-22 N/A Executive member Sell None 154,000.00 CHF
2023-09-29 N/A Executive member Sell None 40,800.00 CHF
2022-06-23 N/A Non-Executive member Buy None 31,400.00 CHF
2022-06-23 N/A Executive member Buy None 11,760.00 CHF
2022-06-23 N/A Executive member Buy None 122.50 CHF
2022-06-14 N/A Non-Executive member Buy None 1,080,875.72 CHF

Peer Companies

Picard Medical, Inc. Logo
Commercializes the only approved Total Artificial Heart as a bridge to transplant for heart failure.
United States of America
PMI
Plasmapp Co., Ltd. Logo
Develops low-temperature plasma sterilizers and bio-activation tech for the global medical industry.
South Korea
405000
PMD Device Solutions AB Logo
Offered wearable respiratory sensors & remote monitoring for hospitals before bankruptcy.
Sweden
PMDS
PolarCool Logo
Develops a medical cooling system for acute treatment of concussions in sports medicine.
Sweden
POLAR
Primotec Group Ltd. Logo
Provider of digital and classic dental technology solutions for dental laboratories.
Israel
PRMG
Prim S.A. Logo
Designs & manufactures orthopedic and hospital supplies for mobility, rehab, and physiotherapy.
Spain
PRM
PROCEPT BioRobotics Corp Logo
Surgical robotics company providing AI-guided waterjet therapy for BPH treatment in urology.
United States of America
PRCT
PRO DEX INC Logo
Manufactures powered surgical, dental, and rotary drive systems for medical device OEMs.
United States of America
PDEX
Profound Medical Corp. Logo
Develops incision-free, MRI-guided ultrasound therapy for ablating prostate tissue.
United States of America
PROF
Profusa, Inc. Logo
Develops injectable biosensors for continuous, long-term monitoring of body chemistries.
United States of America
PFSA

Talk to a Data Expert

Have a question? We'll get back to you promptly.